2023年ChatGPT醫(yī)療行業(yè)應(yīng)用分析報(bào)告_第1頁(yè)
2023年ChatGPT醫(yī)療行業(yè)應(yīng)用分析報(bào)告_第2頁(yè)
2023年ChatGPT醫(yī)療行業(yè)應(yīng)用分析報(bào)告_第3頁(yè)
2023年ChatGPT醫(yī)療行業(yè)應(yīng)用分析報(bào)告_第4頁(yè)
2023年ChatGPT醫(yī)療行業(yè)應(yīng)用分析報(bào)告_第5頁(yè)
已閱讀5頁(yè),還剩44頁(yè)未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

ChatGPT

Application

in

Healthcare

Report2023年9月101020304

ChatGPT2ChatGPTOpenAIGPTLLMChatGPTChatGPTChatGPT/2020.6.11

GPT-3?GPT-3??2022.11.30

ChatGPT/GPT-3.5ChatGPTGPT-3.5??2023.3.14

GPT-4/??4數(shù)據(jù):OpenAI官網(wǎng)(

/

)2023????5數(shù)據(jù):行業(yè)公開信息整理。ChatGPT6數(shù)據(jù):案例采用ChatGPT(GPT-4模型)對(duì)話。7數(shù)據(jù):案例采用ChatGPT(GPT-4模型)對(duì)話。8數(shù)據(jù):案例采用ChatGPT(GPT-4模型)對(duì)話。20222022OpenAIChatGPTAIChatGPTPaLMPubMedGPT

Med-AIAIAI9數(shù)據(jù):行業(yè)公開信息整理。PubMedGPT?????PubMedGPTStanford

MosaicMLBioMedLM??10數(shù)據(jù):

/stanford-crfm/BioMedLM?????????11數(shù)據(jù):谷歌,https://sites.research.google/med-palm/vs

Med-PaLM85.4908070605040302010067.26050.3PubMedGPTMed-PaLMMed-PaLM2?

Med-PaLM?

Med-PaLM267.285.4AIPubMedGPTMed-PaLMPubMedGPT12數(shù)據(jù):谷歌,https://sites.research.google/med-palm/Dragon??DRAGON??DRAGON

(DeepBidirectional

Language-Knowledge

Graph

Pretraining)Stanford

University-???13數(shù)據(jù):/michiyasunaga/dragon?????HippocraticMedicareJohnsHopkins

Stanford

Google

Nvidia??AIGeneral

CatalystHippocratic”??14數(shù)據(jù):官網(wǎng)()HippocraticGPT-488.6%76.2%Hippocratic

AI92.3%80.3%GPT-4100%90%80%70%60%50%40%30%20%10%0%91.1%83.7%71.4%???72.7%70.9%71.0%65.3%48.5%??15數(shù)據(jù):官網(wǎng)()QALLM???QAQA16數(shù)據(jù):行業(yè)公開信息整理。Question:??A

57-year-old

man

presents

to

his

primary

care

physician

with

a2-month

history

of

right

upper

and

lower

extremity

weakness.He

noticed

the

weakness

when

he

started

falling

far

morefrequently

while

running

errands.

Since

then,

he

has

hadincreasing

difficulty

with

walking

and

lifting

objects.

His

pastmedical

history

is

significant

only

for

well-controlledhypertension,

but

he

says

that

some

members

of

his

family

havehad

musculoskeletal

problems.

His

right

upper

extremity

showsforearm

atrophy

and

depressed

reflexes

while

his

right

lowerextremity

is

hypertonic

with

a

positive

Babinski

sign.

Which

ofthe

following

is

most

likely

associated

with

the

cause

of

thispatients

symptoms??????Options:A:

HLA-B8

haplotype,

B:

HLA-DR2

haplotype,

C:

Mutation

inSOD1,

D:

Mutation

in

SMN1,

E:

Viral

infection???(答案為A)?

MedQA-USMLE?17數(shù)據(jù):/jind11/MedQAQuestion:??Do

preoperative

statins

reduce

atrial

fibrillation

after

coronaryartery

bypass

grafting?Context:(Objective)

Recent

studies

have

demonstrated

that

statins

havepleiotropic

effects,

including

anti-inflammatory

effects

and

atrialfibrillation

(AF)preventive

effects

[...](Methods)

221

patients

underwent

CABG

in

our

hospital

from2004

to

2007.

14

patients

with

preoperative

AF

and

4

patientswith

concomitant

valve

surgery

[...]???(Results)

The

overall

incidence

of

postoperative

AF

was

26%.Postoperative

AF

was

significantly

lower

in

the

Statin

groupcompared

with

the

Non-statin

group

(16%

versus

33%,

p=0.005).[...]???Long

Answer:????(Conclusion)

Our

study

indicated

that

preoperative

statin

therapyseems

to

reduce

AFdevelopment

after

CABG.Answer:yes?

PubMedQAQA18數(shù)據(jù):https://huggingface.co/datasets/pubmed_qaQuestion:??Chronic

urethral

obstruction

due

to

benign

prismatic

hyperplasiacan

lead

to

the

following

change

in

kidney

parenchyma?Options:a)

Hyperplasiab)

Hyperophyc)

Atrophy??d)

DysplasiaCorrect

Answer:

c)

Atrophy??????Explanation:Chronic

urethral

obstruction

because

of

urinary

calculi,

prostatichyperophy,

tumors,

normal

pregnancy[…]Subject:

AnatomyTopic:

Urinary

tract??

MedMCQASubjectTopic19數(shù)據(jù):https://huggingface.co/datasets/medmcqaQuestion:??Cocher

la

(les)

proposition(s)

exacte(s)

:

Le

métronidazoleOptions:a)

Est

un

dérivé

du

pyrazole?b)

Peut

induire

un

effet

antabusec)

Peut

être

administré

par

voie

parentérale

intraveineused)

Peut

être

utilisé

dans

certaines

parasitoses

à

protozoairese)

Est

inefficace

dans

les

infections

à

germes

anaérobies???Correct

Answer:???b)

Peut

induire

un

effet

antabusec)

Peut

être

administré

par

voie

parentérale

intraveineused)

Peut

être

utilisé

dans

certaines

parasitoses

à

protozoaires?

FrenchMedMCQAAI?數(shù)據(jù)20:/dataset/frenchmedmcqaChatGPTChatGPT22注:*

表示潛在的應(yīng)用場(chǎng)景(暫無(wú)落地案例覆蓋)23數(shù)據(jù):

kahun公司官網(wǎng)(

)?ChatGPT?????24注:案例展示為測(cè)試版軟件演示,kahun公司尚未披露產(chǎn)品應(yīng)用后的實(shí)際數(shù)據(jù)。25數(shù)據(jù):公司官網(wǎng)(

)26數(shù)據(jù):官網(wǎng)()/Nabla

Copilot2350%27數(shù)據(jù):截圖來(lái)自軟件試用,指標(biāo)數(shù)據(jù)來(lái)自官網(wǎng)()28數(shù)據(jù):官網(wǎng)(

)29數(shù)據(jù):官網(wǎng)(

),

DocsGPT網(wǎng)站(

www.DocsGPT.com)GPTDocsGPT30數(shù)據(jù):DocsGPT網(wǎng)站(

www.DocsGPT.com)31數(shù)據(jù):官網(wǎng)()??3334數(shù)據(jù):官網(wǎng)()、ChatGPT

Plugin

Store35數(shù)據(jù):官網(wǎng)()、ChatGPT

Plugin

Store?2022

ZHONG

OU

AMC.36數(shù)據(jù):

Clinical

Trial

Radar(ChatGPT插件)37數(shù)據(jù):

Clinical

Trial

Radar(ChatGPT插件)COVID-1938數(shù)據(jù):

Clinical

Trial

Radar(ChatGPT插件)39數(shù)據(jù):官網(wǎng)(www.

www.ferma.ai)信息源回答質(zhì)量1

行業(yè)新聞

生命科學(xué)網(wǎng)站、新聞,官方發(fā)布1

準(zhǔn)確性沒有幻覺(hallucinations)。每個(gè)回答都有引用。FDA

Labeling(藥品和醫(yī)療器械標(biāo)于可溯源、可信任的生命科學(xué)數(shù)據(jù)集。2

藥審監(jiān)管3

財(cái)經(jīng)信息4

醫(yī)學(xué)數(shù)據(jù)

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論